RNA Manufacturing Solutions

  1. Plasmid DNA Production 6/23/2022

    Integrated manufacturing supporting cell and gene therapies.

    The critical genetic foundation for advanced therapies

    Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.

  2. Biologics Development 5/15/2024

    We offer industry-leading biologics development services to support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.

  3. Automated Single-Use Filtration System For Small-Scale Manufacturing 11/15/2017

    This automated single-use filtration system for pilot- and small-scale manufacturing features a single-use flow path that addresses the bioburden challenge, reducing the need for cleaning to shorten batch changeover time.

  4. CD34+ HSC LNP Kits 4/24/2025

    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  5. Modular Environments For Biomanufacturing Capacity 9/16/2024

    Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

  6. Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics 2/9/2026

    Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.

  7. High‑Purity Nucleoside Triphosphates 3/13/2026

    High‑purity nucleoside triphosphates are essential for reliable mRNA production. Learn more about their quality specifications, consistency, and regulatory support for production workflows.

  8. Control Software For Industrial Applications 5/1/2026

    Learn how integrated process control, scalable workflows, and secure automation help teams plan, run, and analyze bioprocesses efficiently across research, development, and manufacturing.

  9. Oligonucleotide Synthesis Solutions 12/9/2024

    Discover innovative approaches to oligonucleotide synthesis, showcasing their superior performance compared to traditional liquid chromatography methods.

  10. mRNA Raw Materials: Supporting Your Journey To Market 12/5/2025

    Implementing a quality-by-design approach for manufacturing inputs limits contamination risks and simplifies regulatory compliance. Validated processes ensure consistency when scaling operations.